Emergent BioSolutions (EBS) Receivables - Other (2017 - 2026)
Emergent BioSolutions (EBS) posted Receivables - Other of $16.6 million for Q3 2026, down 14.0% from $19.3 million a year earlier and down 21.7% from the prior quarter.
Powered by 
Analysis
Emergent BioSolutions (EBS) Receivables - Other (2017 - 2026) Analysis & Trends
At the end of FY2025, Emergent BioSolutions' Receivables - Other came in at $18.2 million, down 7.1% from FY2024.
- Annual Receivables - Other has declined for three consecutive years, with a five-year compound annual growth rate of -20.7% (FY2020 to FY2025).
- In prior years, Emergent BioSolutions' Receivables - Other was $19.6 million in FY2024 (-61.9%), $51.4 million in FY2023 (-10.1%), $57.2 million in FY2022 (+10.9%) and $51.6 million in FY2021 (-11.3%).
- The Q3 2026 figure stands as the lowest quarterly Receivables - Other in data going back to Q4 2017.
- On a year-over-year basis, Receivables - Other has declined in each of the last four quarters, with an average decline of 28.6% over the last eight quarters.
- The strongest year-over-year quarter for Receivables - Other in the past five years was Q2 2024, with growth of 59.3%; the weakest was Q2 2025, with a decline of 72.2%.
- According to Business Quant data, Receivables - Other for the three prior quarters was $21.2 million (Q2 2026), $18.3 million (Q1 2026) and $18.2 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Emergent BioSolutions | 310.37 Mn | -370.73 Mn | 29.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 16.60 Mn |
| Jun 30, 2026 | 21.20 Mn |
| Mar 31, 2026 | 18.30 Mn |
| Dec 31, 2025 | 18.20 Mn |
| Sep 30, 2025 | 19.30 Mn |
| Jun 30, 2025 | 22.90 Mn |
| Mar 31, 2025 | 30.90 Mn |
| Dec 31, 2024 | 19.60 Mn |
| Sep 30, 2024 | 19.20 Mn |
| Jun 30, 2024 | 82.50 Mn |
| Mar 31, 2024 | 41.60 Mn |
| Dec 31, 2023 | 51.40 Mn |
| Sep 30, 2023 | 61.00 Mn |
| Jun 30, 2023 | 51.80 Mn |
| Mar 31, 2023 | 49.80 Mn |
| Dec 31, 2022 | 57.20 Mn |
| Sep 30, 2022 | 72.30 Mn |
| Jun 30, 2022 | 55.10 Mn |
| Mar 31, 2022 | 66.60 Mn |
| Dec 31, 2021 | 51.60 Mn |
API Access
Emergent BioSolutions Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();